SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: MulhollandDrive who wrote (1406)6/8/1998 11:33:00 AM
From: Rudy Saucillo  Read Replies (1) | Respond to of 2173
 
Betty Ann,

PRNewswire was flooded this morning with 15 separate announcements of a new pramlintide clinical trial. Kind of surprising and, IMO, distasteful from a hype perspective (this is not how trial sites typically advertise for patient volunteers). Anyway, this may be the reason for today's pop.

Regarding a new partnership, I don't expect a new deal until after results from the Euro trial are known.

Rudy